Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published:October 24, 2024 Post category:News Feed Post comments:0 Comments Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like Myths about intermittent fasting, debunked June 26, 2024 Protein discovery could help solve prostate cancer drug resistance January 23, 2024 Study in mice uncovers new protective benefit of breast milk January 25, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.